• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

野生型p53的两种多态性变体在生化和生物学方面存在差异。

Two polymorphic variants of wild-type p53 differ biochemically and biologically.

作者信息

Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G

机构信息

International Centre for Genetic Engineering and Biotechnology, I-34012 Trieste, Italy.

出版信息

Mol Cell Biol. 1999 Feb;19(2):1092-100. doi: 10.1128/MCB.19.2.1092.

DOI:10.1128/MCB.19.2.1092
PMID:9891044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC116039/
Abstract

The wild-type p53 protein exhibits a common polymorphism at amino acid 72, resulting in either a proline residue (p53Pro) or an arginine residue (p53Arg) at this position. Despite the difference that this change makes in the primary structure of the protein resulting in a difference in migration during sodium dodecyl sulfate-polyacrylamide gel electrophoresis, no differences in the biochemical or biological characteristics of these wild-type p53 variants have been reported. We have recently shown that p53Arg is significantly more susceptible than p53Pro to the degradation induced by human papillomavirus (HPV) E6 protein. Moreover, this may result in an increased susceptibility to HPV-induced tumors in homozygous p53Arg individuals. In further investigating the characteristics of these p53 variants, we now show that both forms are morphologically wild type and do not differ in their ability to bind to DNA in a sequence-specific manner. However, there are a number of differences between the p53 variants in their abilities to bind components of the transcriptional machinery, to activate transcription, to induce apoptosis, and to repress the transformation of primary cells. These observations may have implications for the development of cancers which harbor wild-type p53 sequences and possibly for the ability of such tumors to respond to therapy, depending on their p53 genotype.

摘要

野生型p53蛋白在氨基酸72位存在一种常见的多态性,导致该位置出现脯氨酸残基(p53Pro)或精氨酸残基(p53Arg)。尽管这种变化导致蛋白质一级结构不同,进而在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳中迁移率不同,但尚未报道这些野生型p53变体在生化或生物学特性上存在差异。我们最近发现,p53Arg比p53Pro对人乳头瘤病毒(HPV)E6蛋白诱导的降解更敏感。此外,这可能导致纯合p53Arg个体对HPV诱导的肿瘤易感性增加。在进一步研究这些p53变体的特性时,我们现在发现这两种形式在形态上都是野生型,并且在以序列特异性方式结合DNA的能力上没有差异。然而,p53变体在结合转录机制成分、激活转录、诱导凋亡以及抑制原代细胞转化的能力方面存在许多差异。这些观察结果可能对携带野生型p53序列的癌症的发生发展以及此类肿瘤对治疗的反应能力具有影响,具体取决于它们的p53基因型。

相似文献

1
Two polymorphic variants of wild-type p53 differ biochemically and biologically.野生型p53的两种多态性变体在生化和生物学方面存在差异。
Mol Cell Biol. 1999 Feb;19(2):1092-100. doi: 10.1128/MCB.19.2.1092.
2
p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women.p53基因第72位密码子多态性与韩国女性宫颈癌风险
J Korean Med Sci. 2000 Feb;15(1):65-7. doi: 10.3346/jkms.2000.15.1.65.
3
Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters.宫颈癌中16型人乳头瘤病毒E6变体:与宿主遗传因素及临床参数的关系
J Gen Virol. 1999 Dec;80 ( Pt 12):3233-3240. doi: 10.1099/0022-1317-80-12-3233.
4
Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.突变型p53可在人角质形成细胞永生化过程中替代人乳头瘤病毒16型E6,但不具有E6相关的反式激活或转化活性。
J Virol. 1992 Jul;66(7):4201-8. doi: 10.1128/JVI.66.7.4201-4208.1992.
5
The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells.原发性人宫颈癌中p53的状态及其在人乳头瘤病毒永生化人宫颈细胞中的作用。
Oncogene. 1993 Jun;8(6):1511-8.
6
Molecular analysis of different allelic variants of wild-type human p53.
Biochem Cell Biol. 1992 Oct-Nov;70(10-11):1014-9. doi: 10.1139/o92-145.
7
Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.p53的降解可被HPV E6序列靶向,这些序列不同于p53结合和反式激活所需的序列。
Cell. 1991 Nov 1;67(3):547-56. doi: 10.1016/0092-8674(91)90529-8.
8
Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth.可变剪接的人乳头瘤病毒18型E6*蛋白抑制E6介导的p53降解并抑制转化细胞生长。
Oncogene. 1997 Jul 17;15(3):257-64. doi: 10.1038/sj.onc.1201202.
9
Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.人乳头瘤病毒E6蛋白导致p53肿瘤抑制蛋白的同源物p73功能失活。
Int J Cancer. 2001 Mar 15;91(6):822-7. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1130>3.0.co;2-0.
10
Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.18型人乳头瘤病毒(HPV - 18)E6在体外和体内介导的p53降解比较显示,基于p53结构和细胞类型存在显著差异,但就HPV - 18 E6突变体而言差异不大。
J Gen Virol. 1998 Aug;79 ( Pt 8):1963-70. doi: 10.1099/0022-1317-79-8-1963.

引用本文的文献

1
Association between Gene Mutations and Colorectal Cancer in the Iranian Population: A Systematic Review.伊朗人群中基因突变与结直肠癌的关联:一项系统综述。
Iran J Public Health. 2025 Feb;54(2):309-320.
2
Relationship among Tobacco Habits, Human Papilloma Virus (HPV) Infection, p53 Polymorphism/Mutation, and the Risk of Oral Squamous Cell Carcinoma.烟草习惯、人乳头瘤病毒(HPV)感染、p53多态性/突变与口腔鳞状细胞癌风险之间的关系
J Pharm Bioallied Sci. 2024 Dec;16(Suppl 4):S3424-S3426. doi: 10.4103/jpbs.jpbs_903_24. Epub 2024 Sep 26.
3
Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.尼日利亚良性前列腺增生症的全外显子组测序显示凋亡途径的改变增加。
Prostate. 2024 Apr;84(5):460-472. doi: 10.1002/pros.24662. Epub 2024 Jan 8.
4
DNA Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients.DNA双链断裂反应与修复基因多态性可能影响头颈癌患者的治疗效果和预后。
Cancers (Basel). 2023 Oct 13;15(20):4972. doi: 10.3390/cancers15204972.
5
Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients.乳腺癌患者蒽环类药物所致心脏毒性的种族差异
Biomedicines. 2023 Aug 17;11(8):2286. doi: 10.3390/biomedicines11082286.
6
TP53 and p21 (CDKN1A) polymorphisms and the risk of systemic lupus erythematosus.TP53 和 p21(CDKN1A)多态性与系统性红斑狼疮风险的关联。
Adv Rheumatol. 2023 Aug 21;63(1):43. doi: 10.1186/s42358-023-00320-4.
7
Neither the African-Centric S47 Nor P72 Variant of TP53 Is Associated With Reduced Risk of Febrile Malaria in a Malian Cohort Study.在马里的一项队列研究中,非洲中心 S47 或 P72 变体都与降低发热性疟疾的风险无关。
J Infect Dis. 2023 Jul 14;228(2):202-211. doi: 10.1093/infdis/jiad066.
8
Relationship Between Genetic Polymorphisms in Cell Cycle Regulatory Gene TP53 and Polycystic Ovarian Syndrome: A Case-Control Study and In Silico Analyses.细胞周期调控基因 TP53 遗传多态性与多囊卵巢综合征的关系:病例对照研究及计算机分析。
Biochem Genet. 2023 Oct;61(5):1827-1849. doi: 10.1007/s10528-023-10349-1. Epub 2023 Mar 1.
9
Association between the Arg72Pro Genotypes in the TP53 Gene and Ile655Val in the HER2 Gene and the Risk of Developing Breast Cancer in the Population of Amapá, Northern Brazil.巴西阿马帕地区人群中 TP53 基因 Arg72Pro 基因型和 HER2 基因 Ile655Val 与乳腺癌发病风险的相关性研究。
Asian Pac J Cancer Prev. 2023 Jan 1;24(1):157-162. doi: 10.31557/APJCP.2023.24.1.157.
10
Current insights into the regulation of programmed cell death by TP53 mutation in cancer.当前对癌症中TP53突变调控程序性细胞死亡的见解。
Front Oncol. 2022 Oct 13;12:1023427. doi: 10.3389/fonc.2022.1023427. eCollection 2022.

本文引用的文献

1
Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.p53基因多态性在人乳头瘤病毒相关癌症发生中的作用。
Nature. 1998 May 21;393(6682):229-34. doi: 10.1038/30400.
2
The polyproline region of p53 is required to activate apoptosis but not growth arrest.p53的多聚脯氨酸区域是激活细胞凋亡所必需的,但不是细胞生长停滞所必需的。
Oncogene. 1997 Aug 18;15(8):887-98. doi: 10.1038/sj.onc.1201263.
3
p53, the cellular gatekeeper for growth and division.p53,细胞生长和分裂的守门人。
Cell. 1997 Feb 7;88(3):323-31. doi: 10.1016/s0092-8674(00)81871-1.
4
Identification of a novel p53 functional domain that is necessary for efficient growth suppression.鉴定一种对有效抑制生长必不可少的新型p53功能域。
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15335-40. doi: 10.1073/pnas.93.26.15335.
5
Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.p53诱导的细胞凋亡与其寡聚状态无关,且可被人乳头瘤病毒18型E6蛋白通过泛素介导的降解作用所消除。
Oncogene. 1996 Jul 18;13(2):265-73.
6
Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein.人p53转录激活结构域与TATA盒结合蛋白之间的直接相互作用。
J Biol Chem. 1993 Feb 5;268(4):2284-7.
7
Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.体外p53构象的氧化还原调节及序列特异性DNA结合
Cancer Res. 1993 Oct 1;53(19):4469-73.
8
Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.野生型p53对TATA介导而非起始子介导的转录的特异性抑制。
Nature. 1993 May 20;363(6426):281-3. doi: 10.1038/363281a0.
9
DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6.
Oncogene. 1994 Feb;9(2):629-33.
10
WAF1, a potential mediator of p53 tumor suppression.WAF1,一种p53肿瘤抑制的潜在介导因子。
Cell. 1993 Nov 19;75(4):817-25. doi: 10.1016/0092-8674(93)90500-p.